Human umbilical cord blood mononuclear cell-conditioned media inhibits hypoxic-induced apoptosis in human coronary artery endothelial cells and cardiac myocytes by activation of the survival protein Akt

Cell Transplantation

Volumn 22, Issue 9, 2013, Pages 1637-1650

  Jin, Hua ^a   Sanberg, Paul R ^b   Henning, Robert J ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Akt (protein kinase B); Anti inflammatory cytokines; Apoptosis; Cardiac myocytes; Caspase; Coronary artery endothelial cells; Growth factors; Paracrine actions; Stem cells; Umbilical cord cells

Indexed keywords

ANGIOGENIN; ANGIOPOIETIN; CASPASE 3; CYTOKINE; GROWTH FACTOR; INTERLEUKIN 4; LIPOCORTIN 5; METALLOPROTEINASE; PLACENTAL GROWTH FACTOR; PROTEIN BCL 2; PROTEIN KINASE B; SCATTER FACTOR; SOMATOMEDIN; STEM CELL FACTOR; VASCULOTROPIN;

ACUTE HEART INFARCTION; APOPTOSIS; ARTICLE; CELL FREE SYSTEM; CELL SURVIVAL; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY ENDOTHELIAL CELL; CULTURE MEDIUM; CYTOKINE RELEASE; EMBRYO; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN UMBILICAL CORD BLOOD MONONUCLEAR CELL; HYPOXIA; MESENCHYMAL STEM CELL; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MICROARRAY; UMBILICAL CORD BLOOD; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL HYPOXIA; CELL SURVIVAL; CORONARY VESSELS; CULTURE MEDIA, CONDITIONED; ECHOCARDIOGRAPHY; ENDOTHELIAL CELLS; FEMALE; HUMANS; MALE; MYOCYTES, CARDIAC; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; SIGNAL TRANSDUCTION; UMBILICAL CORD;

EID: 84883531146     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368912X661427     Document Type: Article

References (39)

1. Aikawa, R.; Nawano, M.; Gu, Y.; Katagiri, H.; Asano, T.; Zhu, W.; Nagai, R.; Komuro, I. Insulin prevents cardiomyo-cytes from oxidative stress-induced apoptosis through activation of PI3 kinase/Akt. Circulation 102:2873-2879; 2000.
2. Armstrong, S. C. Protein kinase activation and myocardial ischemia/reperfusion injury. Cardiovasc. Res. 61:427-436; 2004.
3. Berndt, N.; Yang, H.; Trinczek, B.; Betzi, S.; Zhang, Z.; Wu, B.; Lawrence, N.; Pellecchla, M.; Schonbrunn, E.; Cheng, J. Q.; Sebti, S. M. The Akt activation inhibitor TCN-P inhibits Akt phosphorylation by binding to the PH domain of Akt and blocking its recruitment to the plasma membrane. Cell Death Differ. 17:1795-1804; 2010.
4. Burlacu, A.; Grigorescu, G.; Rosca, A.-M.; Preda, M.; Simonescu, M. Factors secreted by mesenchymal stem cells and endothelial progenitor cells have complementary effects on angiogenesis in vitro. Stem Cells Dev. 22:643-653; 2013.
5. Ceci, M.; Gallo, P.; Santonastasi, M.; Grimaldi, S.; Latronico, M. V.; Pitisci, A.; Missol-Kolka, E.; Scimia, M. C; Catalucci, D.; Hilnker-Kleiner, D.; Condorelli, G Cardiac-specific overexpression of E40K active Akt prevents pressure overload-induced heart failure in mice by increasing angiogenesis and reducing apoptosis. Cell Death Differ. 14:1060-1062; 2007.
6. Chen, X. H.; Minatoguchi, S.; Kosai, K. In-vivo hepato-cyte growth factor gene transfer reduces myocardial injury through its multiple actions. J. Cardiac Fail. 13:874-883; 2007.
7. Datta, S.; Dudek, H.; Tao, X.; Masters, S.; Fu, H.; Gotoh, Y.; Greenberg, M. Akt phosphorylation of BAD couples survival signals to cell intrinsic death machinery. Cell 91:231-241; 1997.
8. Deten, A.; Volz, H. C; Briest, W.; Zimmer, H. Cardiac cytokine expression is unregulated in infarction. Cardiovasc. Res. 55:329-340; 2002.
9. Dimmeler, S.; Fleming, I.; Fisslthaler, B.; Hermann, C; Busse, R.; Zeiher, A. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399:601-605; 1999.
10. Frangogiannis, N. Regulation of the inflammatory response in cardiac repair. Circ. Res. 110:159-173; 2012.
11. Fulton, D.; Gratton, J.; McCabe, T.; Fontana, J.; Fujio, Y; Walsh, K.; Franke, T.; Papapetropoulos, A.; Sessa, W. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399:597-601; 1999.
12. Henning, R. J.; Abu-Ali, H.; Balis, J. B.; Morgan, M.; Willing, A.; Sanberg, P. R. Human umbilical cord stem cells in the treatment of acute myocardial infarction. Cell Transplant. 13:729-739; 2004.
13. Henning, R. J.; Aufman, J.; Shariff, M.; Sawmiller, D.; Delostia, V.; Sanberg, P.; Morgan, M. Human umbilical cord stem cells decrease fibrosis and increase cardiac function in cardiomyopathy. Regen. Med. 5:45-54; 2010.
14. Henning, R. J.; Burgos, J. D.; Ondrovic, L.; Sanberg, P.; Balis, J.; Morgan, M. B. Human umbilical cord stem cells are attracted to myocardial infarctions. Cell Transplant. 15:647-658; 2006.
15. Henning, R. J.; Burgos, J. D.; Vasko, M.; Alvarado, F.; Sanberg, C. D.; Sanberg, P. R.; Morgan, M. B. Human umbilical cord stem cells and myocardial infarction: Effect of dose and route of administration on infarct size. Cell Transplant. 16:907-917; 2007.
16. Henning, R. J.; Dennis, S.; Sawmiller, D.; Hunter, L.; Sanberg, P.; Miller, L. Human umbilical cord blood mono-nuclear cells activate the survival protein Akt in cardiac myocytes and endothelial cells that limits apoptosis and necrosis during hypoxia. Translational Res. 159:497-506; 2012.
17. Henning, R. J.; Shariff, M.; Ujwala, E.; Alvarado, E; Vasko, M.; Sanberg, P. R.; Sanberg, C. D.; Delostia, V. Human cord blood mononuclear cells decrease cytokines and inflammatory cells in acute infarcts. Stem Cells Dev. 17:1207-1220; 2008.
18. Hescheler, J.; Meyer, R.; Plant, S.; Krautwurst, D.; Rosenthal, W.; Schultz, G. Morphological, biochemical and electrophysiological characterization of a clonal cell (H9c2) line from rat heart. Circ. Res. 61:1476-1486; 1991.
19. Hori, M.; Nishida, K. Oxidative stress and left ventricular remodeling after myocardial infarction. Cardiovasc. Res. 81:457-464; 2009.
20. Kajstura, J.; Bolli, R.; Sonnenblick, E.; Anversa, P.; Leri, A. Cause of death: Suicide. J. Mol. Cell. Cardiol. 40:425-437; 2006.
21. Kim, D.; Sun, M.; He, L.; Zhou, Q.; Sun, X. M.; Bepler, G; Sebti, S.; Cheng, J. A small molecule inhibits Akt through direct binding to Akt and preventing Akt membrane trans-location. J. Biol. Chem. 285:8383-8394; 2010.
22. Kotlyar, A.; Vered, Z.; Goldberg, I.; Chouraqui, P.; Nas, D.; Friedman, E.; Chen-Levy, Z.; Fytlovich, S.; Sangiorgi, G; Spagnoli, L.; Orlandi, A.; Savion, N.; Eldar, M.; Scheinowitz, M. Insulin-like growth factor I and II preserve myocardial structure in postinfarct swine. Heart 86:693-700; 2001.
23. Laufer, E.; Reutelingsperger, C; Narula, L; Hofstra, L. Annexin A5: An imaging biomarker of cardiovascular risk. Basic Res. Cardiol. 103:95-104; 2008.
24. Lin, Y; Huang, R.; Chen, L. P.; Lisoukov, H.; Lu, Z. H.; Li, S.; Wang, C; Huang, R. P. Profiling of cytokine expression by biotin-labeled-based protein arrays. Proteomics 3:1750-1757; 2003.
25. Lopez, A. D.; Murray, C. The global burden of disease, 1990-2020. Nat. Med. 4:1241-1243; 1998.
26. MacLellan, W. R.; Schneider, M. D. Death by design. Programmed cell death in cardiovascular biology and disease. Circ. Res. 81:137-144; 1997.
27. Madeddu, P.; Kraenkel, N.; Barcelos, L.; Siragusa, M. D.; Campagnolo, P.; Oikawa, A.; Caporali, A.; Herman, A.; Azzolino, O.; Barberis, L.; Perino, A.; Damilano, E; Emanueli, C; Hirsch, E. Phosphoinositide 3-kinase gamma gene knockout impairs postischemic neovascularization and endothelial progenitor cell functions. Arterioscler. Thromb. Vase. Biol. 28:68-76; 2008.
28. Matsui, T.; Li, L.; del Monte, E; Fukui, Y; Frane, T.; Hajjar, R.; Rosenzweig, A. Adenoviral gene transfer of activated phosphatidylinositol 3'-kinase and Akt inhibits apoptosis of hypoxic cardiomyocytes in vitro. Circulation 100:2373-2379; 1999.
29. Mohyeldin, A.; Garzon-Muvdi, T.; Quinones-Hinojos, A. Oxygen in stem cell biology: A critical component of the stem cell niche. Cell Stem Cell 7:150-160; 2010.
30. Neufhoff, S.; Moers, J.; Ricks, M.; Grunwald, T.; Jensen, A.; Dermietzel, R.; Meier, C. Proliferation, differentiation, and cytokine secretion of human umbilical cord blood-derived mononuclear cells in vitro. Exp. Hematol. 35:1119-1131; 2007.
31. Ono, K.; Matsumori, A.; Shioi, T.; Furukawa, Y; Sasayam, S. Cytokine gene expression after infarction in rat: Possible implication in left ventricular remodeling. Circulation 98:149-156; 1998.
32. Overbeeke, R.; Steffens-Nekken, H.; Vermes, I.; Reutelingsperger, C; Haanen, C. Early features of apoptosis detected by four different flow cytometry assays. Apoptosis 3:115-121; 1998.
33. Pesce, M.; Orlandi, A.; lachininoto, M.; Strain, S.; Torella, A.; Rizzuti, V; Pompilio, G; Bonanno, G; Scambia, G; Capogrossi, M. Myoendothelial differentiation of human umbilical cord blood-derived stem cells in ischemic limb tissues. Circ. Res. 93:e51-e62; 2003.
34. Ruvinov, E.; Leor, J.; Cohen, S. The promotion of myocardial repair by the sequential delivery of IGF-1 and HGF from an injectable alginate biomaterial in a model of acute myocardial infarction. Biomaterials 32:565-578; 2011.
35. Sussman, M.; Volkers, M.; Fischer, K.; Bailey, B.; Cottage, C; Din, S.; Gude, N; Avitabile, D.; Alvarez, R.; Sundararaman, B.; Quijada, P.; Mason, M.; Konstandin, M.; Mathowski, A.; Cheng, Z.; Khan, M.; McGregor, M. Myocardial AKT: The omnipresent nexus. Physiol. Rev. 91:1023-1070; 2011.
36. Tucka, J.; Bennett, M.; Littlewood, T. Cell death and survival signaling in the cardiovascular system. Front. Biosci. 17:248-261; 2012.
37. Yamamura, T.; Otani, H.; Nakao, Y. IGF-1 differentially regulates Bcl-xL and Bax and confers myocardial protection in rat heart. Am. J. Physiol. Heart Circ. Physiol. 280:H1191-H1200; 2001.
38. Yang, L.; Dan, H.; Sun, M.; Liu, Q.; Sun, X.-M.; Feldman, R.; Nicosia, S.; Herlyn, M.; Sebti, S.; Cheng, J. Akt/Protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt. J. Cancer Res. 64:4394-4399; 2004.
39. Zordoky, B.; El-Kadi, A. H9c2 cell line is a valuable in vitro model to study the drug metabolizing enzymes in the heart. J. Pharmacol. Toxicol. Methods 56:317-322; 2007.